Kestra Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $101K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $166K | Sell |
|
|||||
|
2023
Q4 | $179K | Buy |
|
|||||
|
2023
Q3 | $188K | Sell |
|
|||||
|
2023
Q2 | $195K | Sell |
|
|||||
|
2023
Q1 | $316K | Sell |
|
|||||
|
2022
Q4 | $572K | Buy |
|
|||||
|
2022
Q3 | $346K | Buy |
|
|||||
|
2022
Q2 | $364K | Buy |
|
|||||
|
2022
Q1 | $315K | Sell |
|
|||||
|
2021
Q4 | $390K | Sell |
|
|||||
|
2021
Q3 | $598K | Sell |
|
|||||
|
2021
Q2 | $620K | Sell |
|
|||||
|
2021
Q1 | $690K | Buy |
|
|||||
|
2020
Q4 | $231K | Buy |
|